Sunday, April 25, 2021

Tata Consumer Stock - A share worth to buy for long term

Tata Consumer Products is an integrated Food & Beverage company headquartered in Mumbai, Maharashtra, India and a subsidiary of the Tata Group. It is amongst the top 10 Food & Beverage companies in India with a vision to become a multi-category FMCG major.

Industry type:

Food Manufacturing
Manufacturing Sector
Food preparations
Tea blending
Instant coffee
Tea
Cat food
Coffee and tea
Management consulting services

SUGGESTION : Very Bullish Stock. This stock is can give profit if the investors who can wait for long time. The stock has consistent financial performance, quality management, and strong technical momentum.

The reason we should invest in Tata Consumer: 

A TATA Group Company.

The Rs 100 crore tea packaging unit of Tata Consumer Products Ltd in Gopalpur Industrial Park in Odisha will commence commercial production soon, with an annual production capacity of 60 million kgs the company said on Friday. 

Tata Consumer Products LTd stock got admitted to the flagship Nifty50 index on March 31.

On a year-to-date basis, the stock has managed to beat both the Nifty50 and Nifty FMCG index in terms of returns.

Tata Consumer is currently undergoing a transformation to become a multi-category FMCG company from a food and beverage (F&B) company.

Tata Consumer plans to double its direct reach to 1 million outlets over 12 months will meaningfully drive volumes and give a strong impetus to its core tea and salt portfolio.


Highlights:

  • Share Price (as on 25/04/2021) - Rs.664.60
  • Technical Rating : Very Bullish
  • Cash from Operating Activity - Increasing Yearly Drastically (~1082 Cr)
  • Operating Profit - Increasing Yearly  Drastically (1256 Cr)
  • Promoters - ~ 35% (Increasing Pattern)
  • Foreign Investor - ~25 % (Increasing Pattern)
  • Sales - Increasing Drastically
  • Reserves - ~10700 Cr (Increasing Yearly  Drastically )
  • Long term Borrowing  - 0
  • Cash & Cash equivalent - Increasing Pattern
  • TTM PE Ratio - Market Leader
  • Price to Book Ratio - High in industry


                                                                                                                                           
    

3 years CAGR growth

                       Revenue                                         12.4%
                  Net Profit                                       5.7%
                  Operating Profit                                                17.8%


Five year's performance
The stock is performing well since 2019 consistently and as of now we can see no reason it will not perform well in future. 

                                                Revenue



Thanks & regards


No comments:

Vaccination fraud alert!!!!!!!!!